Published in
Springer, Breast Cancer Research and Treatment, 3(169), p. 469-479, 2018
DOI: 10.1007/s10549-017-4658-x
Links
Tools
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
Journal article published in 2018 by
Wolfgang Janni 
,
Emilio Alba,
Thomas Bachelot,
Sami Diab,
Miguel Gil-Gil,
Thaddeus J. Beck,
Larisa Ryvo,
Rafael Lopez ,
Michaela Tsai,
Francisco J. Esteva,
Pilar Zamora Auñón,
Zdenek Kral,
Patrick Ward ,
Paul Richards,
Timothy J. Pluard
and other authors.
,
Emilio Alba,
Thomas Bachelot,
Sami Diab,
Miguel Gil-Gil,
Thaddeus J. Beck,
Larisa Ryvo,
Rafael Lopez ,
Michaela Tsai,
Francisco J. Esteva,
Pilar Zamora Auñón,
Zdenek Kral,
Patrick Ward ,
Paul Richards,
Timothy J. Pluard
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 